Sun Pharmaceutical Industries LimitedNSE: SUNPHARMA

Sun Pharmaceutical Industries Limited Press Release Jul 26 2024

Jul 25, 2024 at 7:40 PM EDT · Issued by Sun Pharmaceutical Industries Limited via NSE India

Filed with NSE · Jul 25, 2024 at 7:40 PM EDT · 7 pages · English

On 6ix: 6ix.com/news/sun-pharmaceutical-industries-limited-press-release-jul-26-2024

Watch Sun Pharmaceutical Industries' latest callSun Pharmaceutical Industries (NSE:SUNPHARMA) Q1 2027 Earnings Call · Replay · Jul 31 Read the transcript of Sun Pharmaceutical Industries (NSE:SUNPHARMA) Q1 2027 Earnings Call

Release

Sun Pharmaceutical Industries Limited has informed the Exchange regarding a press release dated July 26, 2024, titled "Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 U.S. FDA Approves LEQSELVI (deuruxolitinib)".

Sun Pharmaceutical Industries Limited on 6ix

Earlier from Sun Pharmaceutical Industries

Later from Sun Pharmaceutical Industries

All Sun Pharmaceutical Industries news releases

Follow Sun Pharmaceutical Industries into a list and get an email when it puts out news.

Follow Sun Pharmaceutical Industries